Scientific Quality
The scientific quality of publications in IJCCD is maintained through rigorous peer review processes and oversight by an eminent editorial team. The journal is committed to upholding the highest standards of scientific rigor, editorial excellence, and ethical integrity, including full transparency in reporting experimental details so that others may reproduce and extend the findings.
Scientific and Editorial Quality Standards
IJCCD ensures that all published articles meet rigorous quality standards by evaluating:
Scientific Rigor: Clear statement of study aims, well-justified research questions, detailed methodology that allows reproducibility, appropriate and up-to-date references, and transparent reporting of data
Editorial Quality: Clear and effective writing, high-quality figures and tables, proper data presentation, and adherence to reporting guidelines
Research Integrity: Appropriate experimental design, unbiased analysis and interpretation, proper statistical methods, and ethical compliance
Reporting Guidelines
IJCCD strongly encourages authors to follow reporting guidelines to ensure transparency and reproducibility. Resources that authors are encouraged to reference include:
Human research: Helsinki Declaration as revised in 2013
Systematic reviews and meta-analyses: PRISMA guidelines (for protocols, see the PRISMA-P guidelines)
For a comprehensive list of reporting guidelines, please see the Research and Reporting Guidelines list maintained by the National Library of Medicine.
Concerns About Published Articles
If any allegation is made against a published article, all members of the editorial board will be notified of the allegation. It is mandatory that the person who raises the allegation disclose any conflict of interest. Two of the most appropriate board members will be assigned the task of investigating the case. After a thorough investigation, they will make a recommendation to the editor-in-chief. The editor-in-chief will either dismiss the allegation or publish a correction or retraction. The editor-in-chief will make a decision based on the recommendation. The decisions will be published.
If the allegation is against a manuscript published by a member of the editorial team, then it will be handled by the publisher, independent of the editorial team. A minimum of two experts will be assigned the task of investigating the case. To maintain transparency, the actions taken and the outcome will be published.
Concerns About Accepted, But Not Yet Published Articles
Accepted articles undergo scientific and copy editing by the in-house editorial team before being published. If any concerns are noticed at this stage, they will be brought to the attention of the managing editor. The managing editor will discuss the issue with the authors, and the article will be published only if the concerns are fully addressed.
Appeal for Fair Review
If an author believes that his or her article has not received a fair review and/or has been rejected unjustly, the corresponding author can make an official complaint via the journal's contact email. Again, a similar procedure as described above will be followed. The editor-in-chief will make the final decision based on the recommendation from the editorial board members. This will be final, and no further appeal is possible.
If the appeal is from one of the editorial team members about his or her article, then it will be handled by the publisher independent of the editorial team, as described above. The decision of the independent experts will be final, and a copy of the decision will be sent to the author.
Commitment to Quality
IJCCD is committed to maintaining the highest standards of scientific and editorial quality to serve as a trusted resource for the global oncology community. The journal adheres to best practices in scientific publishing and continuously works to improve the quality and impact of published research in cancer care and delivery.